| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ce169b3eae4e6a155a90b25c7433a9c9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0b75a05785dbfd86d27a87ddcdc5a524
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_30c2c819835b507b2baab913ca003d48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fce99b7c01b6d76d9e16746c70de2bc5 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4412
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-497
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-02 |
| filingDate |
2010-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2013-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd38a2a6e31635e133fb37b3c73afebb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95cc71da54c4505988977f1b1b2a6c92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c5e9c3e0def557107c63a3825c31daf |
| publicationDate |
2013-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8377932-B2 |
| titleOfInvention |
Preparation of 1-(substituted benzyl)-5-trifluoromethyl-2(1H)pyridone compounds and salts thereof and their applications |
| abstract |
1-(substituted benzyl)-5-trifluoromethyl-2(1H)pyridone compounds and their pharmaceutical acceptable salts are disclosed. The preparation methods of the compounds and their salts and the use of the same for preparing the medicaments for treating fibrosis are also disclosed. New pyridine compounds and their salts are obtained from trifluoromethyl pyridone as starting material. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9675593-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9902712-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9359379-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10898474-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-RE47142-E
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10233195-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10376497-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10544161-B2 |
| priorityDate |
2009-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |